STOCK TITAN

Upexi Inc - UPXI STOCK NEWS

Welcome to our dedicated page for Upexi news (Ticker: UPXI), a resource for investors and traders seeking the latest updates and insights on Upexi stock.

Upexi Inc (UPXI) delivers innovative consumer products through direct-to-consumer platforms and Amazon distribution. This news hub provides investors and stakeholders with essential updates on operational developments, product launches, and strategic initiatives across its diversified portfolio.

Access timely press releases covering earnings announcements, manufacturing advancements, and market expansions in sectors ranging from hemp-derived wellness products to educational toys. Our curated collection ensures transparent tracking of UPXI's restructuring efforts, cost optimization measures, and emerging digital asset ventures.

Discover updates on key business segments including nutraceutical innovations, private label partnerships, and quality control improvements from their in-house production facility. Regular updates provide insights into UPXI's dual focus on maintaining traditional manufacturing excellence while exploring cryptocurrency investments.

Bookmark this page for streamlined access to verified information about UPXI's operational milestones. Check back frequently for objective reporting on consumer trends, ecommerce strategies, and financial developments relevant to this multi-industry operator.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.16%
Tags
-
Rhea-AI Summary
Upexi, Inc. (NASDAQ:UPXI) has entered into definitive agreements with investors to sell 2,121,213 shares of common stock at $3.30 per share, resulting in gross proceeds of approximately $7 million. The offering is expected to close on May 16, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.66%
Tags
-
Rhea-AI Summary
Upexi Inc. will host a conference call on May 15, 2023, to discuss its fiscal 2023 third quarter financial results and provide a business update.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.48%
Tags
conferences earnings
Rhea-AI Summary
Upexi Inc. announces licensing agreement with Disney for its children's toy brand Tytan Tiles. New branded products to be launched on Amazon, direct to consumer, and in retail channels for the 2023 holiday season.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.24%
Tags
none
-
Rhea-AI Summary

Upexi Inc. (NASDAQ:UPXI) has announced a significant operational change, consolidating its logistics operations in Florida. By shutting down its California Third Party Logistics (3PL) site and reducing its Nevada operations, Upexi aims to enhance efficiency and lower expenses. This strategic move is expected to yield annual cost savings of approximately $1 million to $1.5 million over the next six months. CEO Allan Marshall emphasized the importance of streamlining operations to improve customer experience and overall company performance. Upexi operates in the health, wellness, pet, and beauty sectors, focusing on eCommerce growth and customer data accumulation to drive sales.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.43%
Tags
none
-
Rhea-AI Summary

Upexi Inc. (NASDAQ:UPXI) has signed a non-binding Letter of Intent to acquire a Texas-based wellness and nutrition brand specializing in superfoods for $2.5 million, which includes $2 million in cash and $500,000 in Upexi stock. The Acquired Company generated approximately $15 million in trailing twelve-month revenue. This acquisition aligns with Upexi's strategy to acquire profitable, high-margin brands and is expected to yield significant cost synergies. The deal, pending due diligence, is expected to close in May. Upexi aims to expand its portfolio in the health and wellness sector while leveraging its programmatic ad technology to enhance customer acquisition and cross-selling opportunities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.13%
Tags
Rhea-AI Summary

Upexi Inc. (NASDAQ:UPXI) announced its acquisition of the remaining 45% interest in Cygnet Online LLC, an established Amazon seller with over 1,200 active SKUs in OTC products. This strategic move, valued at $1.95 million in structured cash payments over the next 12 months, enhances Upexi's eCommerce presence and aligns with its Amazon reseller strategy. Cygnet generated over $29.5 million in sales in 2022, demonstrating a history of growth in the OTC, supplements, and beauty markets. The acquisition is expected to foster synergy, increasing both product offerings and total sales. Upexi's CEO noted that the deal will reduce overall costs and expects continued strong performance despite economic challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.41%
Tags
-
Rhea-AI Summary

Upexi (NASDAQ: UPXI) announced that its CEO, Allan Marshall, will attend the 35th Annual Roth Conference in Dana Point, CA from March 12-14, 2023. This event provides an opportunity for Upexi's leadership to engage with the investment community through one-on-one meetings. The company focuses on health, wellness, beauty, and pet care sectors, aiming for growth through direct-to-consumer channels and acquisitions of eCommerce businesses. Upexi leverages in-house technology to optimize marketing and enhance customer data accumulation, which has been vital for year-over-year sales and profit increases.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.26%
Tags
conferences
-
Rhea-AI Summary

Upexi Inc. (NASDAQ: UPXI) announced that its Tytan Tiles toy brand exceeded sales projections in its launch at 2,200 Walmart locations. Due to strong demand, Walmart has placed an additional order, nearly doubling initial forecasts for the first half of 2023. Furthermore, Tytan Tiles will expand to over 3,900 stores in the second half of 2023. CEO Allan Marshall highlighted the brand's success in validating the educational toy market, with plans for more product launches. Upexi aims to leverage this momentum to exceed internal sales forecasts for 2023 as it rolls out on Amazon and expands its market presence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Upexi, Inc. (NASDAQ: UPXI) reported strong fiscal 2023 Q2 results, with revenue soaring to $27.1 million, up 444% year-over-year. Gross profit also increased, reaching $10.3 million, a 141% jump. The company achieved an Adjusted EBITDA of $119,054, recovering from a loss of $1.3 million a year ago. A net income of $2.7 million was posted, aided by a one-time gain of $7.6 million from asset sales. Shareholder equity rose to $36.9 million, and cash reserves stood at $4.5 million. CEO Allan Marshall anticipates further operational efficiency and a projected revenue goal of $100 million for calendar 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.39%
Tags
Upexi Inc

Nasdaq:UPXI

UPXI Rankings

UPXI Stock Data

3.29M
1.03M
22.11%
1.18%
1.57%
Internet Content & Information
Medicinal Chemicals & Botanical Products
Link
United States
TAMPA